版本:
中国

BRIEF-BioLineRx to begin late-stage study testing stem cell treatment

May 3 Bioline Rx Ltd

* Biolinerx to initiate phase 3 study with bl-8040 as novel stem cell mobilization treatment following successful meeting with fda

* Bioline rx ltd- initiation of phase 3 registrational study expected in second half of the year for bl-8040

* Bioline rx ltd- initiation of phase 3 registrational study expected in second half of this year

* Bioline rx ltd- met with u.s. Fda and has gained clarity on development program and design of a phase 3 pivotal study for bl-8040 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐